Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5521219 | Drug Discovery Today: Disease Models | 2016 | 4 Pages |
Abstract
Analysis of the brain as a dynamical system can assist drug development for dynamical diseases such as epilepsy. The pathological trajectories that make up a seizure differ significantly from the physiological trajectories of normal brain function. These trajectories depend on parameters - conductances and time constants of ion channels and synapses - that can be modified by drugs. Drug development will benefit by taking account of the way in which multiple parameters - multiple drug targets - produce trajectory alterations. This may lead us to reconsider potential benefits of multi-target polypharmacy, of drug cocktails, and of so-called 'dirty drugs' (drugs with activity at multiple locations).
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
William W. Lytton,